OVERVIEW

Cancer Drug Development Forum (CDDF) Multi-Stakeholder Workshop 2024 is organized by Cancer Drug Development Forum (CDDF) and will be held from Apr 15 - 16, 2024 at AC Hotel by Marriott Krakow, Krakow, Lesser Poland, Poland.

Event Outline:
• This workshop focuses on the fast-developing clinical trial landscape in Central and Eastern Europe (CEE), by bringing key stakeholders and international experts from regulatory
agencies, state research organisations, pharmaceutical industry, academia, and patient advocacy organisations together for open discussions of the current state of play, important
challenges and collaborative next steps to enhance innovation in the region.
• The CEE region in the European Union is delivering strongly increasing numbers of clinical trials, driving the development of clinical research hubs by multinational pharmaceutical
companies, and – most remarkably – empowering a growing regional pharmaceutical industry.
• The war in Ukraine has severely disrupted cancer care and clinical trials in the country/region. Other countries in the region, esp. Poland, have stepped up to care for Ukrainian patients.
The global impact of this crisis has brought support from international organisations. We will discuss how best to support ongoing cancer care and clinical research in the region, given
these challenges.
• Another key aspect of the workshop is to foster collaboration between key stakeholders to address some of the challenges that are particular to the region.
• One of the especially important topics is patient access to innovative drugs, including crossborder access to clinical trials.
• The workshop will involve engaging lectures, intensive discussions with the in-room and online audience, as well as Q&A sessions with panels of experts. It aims to create enduring
connections to support the further development of clinical trials in the region.
• A White paper from the Workshop will provide key recommendations on the direction of travel and how best to boost clinical research and clinical trials and enhance patient care in the
region

Learning objectives
• Enhance innovation and foster collaboration between key stakeholders in Central and Eastern Europe.
• Ensure the adequate support in ongoing cancer care and clinical research in the region, considering the political context.
• Ensure patient access to innovative drugs, including the cross-border access to clinical trials.

Additional details will be posted as soon as information is available.